7-Deaza-2′-deoxyguanosine 5′-triphosphate
7-Deaza-2′-deoxyguanosine 5′-triphosphate structure
|
Common Name | 7-Deaza-2′-deoxyguanosine 5′-triphosphate | ||
|---|---|---|---|---|
| CAS Number | 101515-08-6 | Molecular Weight | 512.12600 | |
| Density | 2.48 g/cm3 | Boiling Point | 907.1ºC at 760 mmHg | |
| Molecular Formula | C11H16LiN4O13P3 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 502.4ºC | |
Use of 7-Deaza-2′-deoxyguanosine 5′-triphosphate7-Deaza-2′-deoxyguanosine 5′-triphosphate (7-Deaza-2'-dGTP), a nucleotide analogue, is a telomerase inhibitor (IC50: 11 μM)[1]. |
| Name | [[5-(2-amino-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate |
|---|---|
| Synonym | More Synonyms |
| Description | 7-Deaza-2′-deoxyguanosine 5′-triphosphate (7-Deaza-2'-dGTP), a nucleotide analogue, is a telomerase inhibitor (IC50: 11 μM)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 2.48 g/cm3 |
|---|---|
| Boiling Point | 907.1ºC at 760 mmHg |
| Molecular Formula | C11H16LiN4O13P3 |
| Molecular Weight | 512.12600 |
| Flash Point | 502.4ºC |
| Exact Mass | 512.00900 |
| PSA | 298.24000 |
| LogP | 0.31790 |
| Vapour Pressure | 1.76E-35mmHg at 25°C |
| Index of Refraction | 1.854 |
| RIDADR | NONH for all modes of transport |
|---|
|
Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.
Neurosci. Lett. 590 , 116-20, (2015) Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET182C) polymorphisms are associated with susceptibility and treatment response in major depressive disorder (MDD). Thus, we examined ... |
|
|
5-HTTLPR genotype, asthma, diabetes and late-life depression in an older French population.
Int. J. Geriatr. Psychiatry 30 , 1017-22, (2015) Associations between environmental risk factors and depression have been reported to be stronger in people with the S allele of the S/L polymorphism in the serotonin transporter gene-linked promoter r... |
|
|
Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation.
Amyotroph. Lateral Scler. Frontotemporal Degener. 15(7-8) , 569-80, (2014) Our objective was to present clinicopathologic evidence of anterior visual pathway involvement in patients with amyotrophic lateral sclerosis (ALS) secondary to a C9orf72 mutation. Two related patient... |
| 7-Deaza-2 inverted exclamation marka-deoxyguanosine 5 inverted exclamation marka-triphosphate lithium salt |
| 7-Deaza-dGTP |